Antagonisierung der oralen
Antikoagulation bei intrakraniellen Blutungen

J Bösel; T Steiner

doi:10.1055/s-0030-1269401

DMW - Deutsche Medizinische Wochenschrift, Inhaltsverzeichnis

Dtsch Med Wochenschr 2010; 135(47): 2366-2369
DOI: 10.1055/s-0030-1269401

Aktuelle Diagnostik & Therapie | Review article

Intensivmedizin, Neurologie
© Georg Thieme Verlag KG Stuttgart · New York

Antagonisierung der oralen Antikoagulation bei intrakraniellen Blutungen

Reversal of oral anticoagulation in intracranial hemorrhageJ. Bösel¹ , T. Steiner¹

¹Neurologische Klinik und Poliklinik, Universitätsklinikum Heidelberg

Abstract

Schlüsselwörter

intrakranielle Blutungen - orale Antikoagulation - Antagonisierung

Keywords

intracerebral hemorrhage - oral anticoagulation - reversal

Volltext

Referenzen

Literatur

1 Aguilar M I, Hart R G, Kase C S. et al . Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. Mayo Clin Proc. 2007; 82 82-92
2 Ansell J, Hirsh J, Dalen J. et al . Managing oral anticoagulant therapy. Chest. 2001; 119 22S-38S
3 Broderick J, Connolly S, Feldmann E. et al . Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke. 2007; 38 2001-2023
4 Davis S M, Broderick J, Hennerici M. et al . Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology. 2006; 66 1175-1181
5 Eckman M H, Rosand J, Knudsen K A, Singer D E, Greenberg S M. Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke. 2003; 34 1710-1716
6 Flaherty M L, Kissela B, Woo D. et al . The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology. 2007; 68 116-121
7 Flibotte J J, Hagan N, O’Donnell J, Greenberg S M, Rosand J. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology. 2004; 63 1059-1064
8 Franke C L, de Jonge J, van Swieten J C, Op de Coul A A, van Gijn J. Intracerebral hematomas during anticoagulant treatment. Stroke. 1990; 21 726-730
9 Gilstad C W. Anaphylactic transfusion reactions. Curr Opin Hematol. 2003; 10 419-423
10 Hanley J P. Warfarin reversal. J Clin Pathol. 2004; 57 1132-1139
11 Hart R G, Boop B S, Anderson D C. Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke. 1995; 26 1471-1477
12 Hellstern P, Halbmayer W M, Kohler M, Seitz R, Muller-Berghaus G. Prothrombin complex concentrates: indications, contraindications, and risks: a task force summary. Thromb Res. 1999; 95 S3-6
13 Huttner H B, Steiner T. Coagulopathy-related intracerebral hemorrhage. In: Carhuapoma JR, Mayer SA, Hanley DF Textbook of Intracerebral Hemorrhage. Cambridge University Press; 2010: 58-70
14 Morgenstern L B, Hemphill 3rd J C, Anderson C. et al . Guidelines for the Management of Spontaneous Intracerebral Hemorrhage. A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2010; 41 2108-2129
15 Pomper G J, Wu Y, Snyder E L. Risks of transfusion-transmitted infections: 2003. Curr Opin Hematol. 2003; 10 412-418
16 Rosand J, Eckman M H, Knudsen K A, Singer D E, Greenberg S M. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med. 2004; 164 880-884
17 Seitz R, Dodt J. Virus safety of prothrombin complex concentrates and factor IX concentrates. Thromb Res. 1999; 95 S19-23
18 Skolnick B E, Mathews D R, Khutoryansky N M, Pusateri A E, Carr M E. Exploratory study on the reversal of warfarin with rFVIIa in healthy subjects. Blood. 2010; 116 693-701
19 Steiner T, Forsting M, Haman G. et al .Intrazerebrale Blutungen. In: Diener H-C, Putzki N, Berlit P et al. Leitlinien für Diagnose und Therapie neurologischer Krankheiten. Thieme Verlag. Stuttgart; 2008: 317-333
20 Steiner T, Kaste M, Forsting M. et al . Recommendations for the management of intracranial haemorrhage – part 1: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cerebrovasc Dis. 2006; 22 294-316
21 Tuhrim S, Horowitz D R, Sacher M, Godbold J H. Volume of ventricular blood is an important determinant of outcome in supratentorial intracerebral hemorrhage. Crit Care Med. 1999; 27 617-621
22 Yasaka M, Sakata T, Minematsu K, Naritomi H. Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication. Thromb Res. 2002; 108 25-30

Dr. Julian Bösel

Neurologische Klinik und Poliklinik
Universitätsklinikum Heidelberg

Im Neuenheimer Feld 400

69120 Heidelberg

eMail: Julian.Boesel@med.uni-heidelberg.de